您的位置: 首页 > 农业专利 > 详情页

Chimeric antigen receptors targeting GPC3 and uses thereof
专利权人:
Carsgen Therapeutics Limited
发明人:
Zonghai Li,Huiping Gao,Hua Jiang,Bizhi Shi,Huamao Wang,Kesang Li,Hongyang Wang,Shengli Yang,Jianren Gu
申请号:
US14889778
公开号:
US10731127B2
申请日:
2014.05.06
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A nucleic acid encoding a chimeric antigen receptor expressed at surface of a T lymphocyte, said chimeric antigen receptor comprises, connected in the order of, an extracellular binding domain, a transmembrane region, and an intracellular signaling domain, wherein the extracellular binding domain comprises a single chain antibody, scFv(GPC3), which specifically recognizes the C-terminal epitope of GPC3. A genetically modified T lymphocyte having a chimeric antigen receptor expressed at surface thereof, and the chimeric antigen receptor is expressed by the nucleic acid described above.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充